Deciphera Pharmaceuticals, Inc. Debt to Equity Ratio 2018-2024 | DCPH
Current and historical debt to equity ratio values for Deciphera Pharmaceuticals, Inc. (DCPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Deciphera Pharmaceuticals, Inc. debt/equity for the three months ending March 31, 2024 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $0.11B | $0.32B | 0.33 |
| 2023-12-31 | $0.12B | $0.35B | 0.35 |
| 2023-09-30 | $0.12B | $0.38B | 0.30 |
| 2023-06-30 | $0.11B | $0.40B | 0.26 |
| 2023-03-31 | $0.11B | $0.44B | 0.25 |
| 2022-12-31 | $0.11B | $0.34B | 0.33 |
| 2022-09-30 | $0.10B | $0.37B | 0.27 |
| 2022-06-30 | $0.10B | $0.41B | 0.25 |
| 2022-03-31 | $0.11B | $0.27B | 0.42 |
| 2021-12-31 | $0.13B | $0.31B | 0.41 |
| 2021-09-30 | $0.10B | $0.38B | 0.27 |
| 2021-06-30 | $0.09B | $0.45B | 0.21 |
| 2021-03-31 | $0.09B | $0.50B | 0.18 |
| 2020-12-31 | $0.10B | $0.54B | 0.18 |
| 2020-09-30 | $0.09B | $0.57B | 0.16 |
| 2020-06-30 | $0.07B | $0.62B | 0.11 |
| 2020-03-31 | $0.06B | $0.67B | 0.09 |
| 2019-12-31 | $0.08B | $0.55B | 0.14 |
| 2019-09-30 | $0.04B | $0.61B | 0.07 |
| 2019-06-30 | $0.04B | $0.22B | 0.17 |
| 2019-03-31 | $0.03B | $0.24B | 0.12 |
| 2018-12-31 | $0.04B | $0.28B | 0.13 |
| 2018-09-30 | $0.04B | $0.31B | 0.12 |
| 2018-06-30 | $0.04B | $0.33B | 0.11 |
| 2018-03-31 | $0.02B | $0.17B | 0.11 |
| 2017-12-31 | $0.02B | $0.18B | 0.08 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
